3
Table of Contents
I.
Executive Summary _______________________________________________________ 5
II.
Introduction ____________________________________________________________ 6
III.
OTC Derivatives __________________________________________________________ 7
III.I
Clearing obligation __________________________________________________ 8
III.II
Clearing obligation procedure __________________________________________ 9
III.III
Public register _____________________________________________________ 12
III.IV
Access to a trading venue _____________________________________________ 13
III.V
Non-financial counterparties ___________________________________________ 14
III.VI
Risk mitigation for OTC derivative contracts not cleared by a CCP _________________ 16 IV.
CCP Requirements _______________________________________________________ 23
IV.I
College _________________________________________________________ 23
IV.II
Recognition of a CCP _______________________________________________ 24
IV.III
Organisational requirements ___________________________________________ 25
IV.IV
Record keeping ___________________________________________________ 28
IV.V
Business continuity ________________________________________________ 29
IV.VI
Margins ________________________________________________________ 29
IV.VII
Default fund ______________________________________________________33
IV.VIII
Liquidity risk controls ______________________________________________ 34
IV.IX
Default waterfall ___________________________________________________ 35
IV.X
Collateral requirements _____________________________________________ 36
IV.XI
Investment policy _________________________________________________ 38
IV.XII
Review of models, stress testing and back testing ____________________________ 40 V.
Trade Repositories _______________________________________________________ 43
V.I
Reporting obligation _______________________________________________ 44
V.II
Application for registration ____________________________________________ 51
V.III
Transparency and data availability _______________________________________ 53 ANNEX I - Legislative mandate to develop draft technical standards .......................................................... 58
ANNEX II - Draft regulatory technical standards on OTC derivatives .......................................................... 62
ANNEX III - Draft regulatory technical standards on CCP requirements ..................................................... 79
ANNEX IV - Draft implementing technical standards on record keeping requirements for CCPs............ 128
ANNEX V - Draft regulatory technical standards on trade repositories ....................................................... 137
ANNEX VI - Draft implementing technical standards on trade repositories ............................................... 167
ANNEX VII - Impact Assessment .................................................................................................................. 178